Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.
Agilent Technologies Inc (A) delivers cutting-edge analytical instruments and laboratory solutions for scientific advancement across biopharmaceutical, diagnostic, and environmental sectors. This page provides investors and industry professionals with a centralized source for all official company announcements and market-relevant developments.
Access real-time updates on Agilent's financial performance, strategic partnerships, product innovations, and regulatory milestones. Our curated news collection includes earnings releases, executive leadership updates, R&D breakthroughs, and industry event coverage—all essential for tracking the company's impact on life sciences and laboratory technology.
Key focus areas include advancements in genomic research tools, sustainability initiatives in lab operations, and cross-sector collaborations driving scientific discovery. Bookmark this page to stay informed about Agilent's evolving role in enabling precision medicine, environmental testing, and next-generation materials analysis.
Rhea-AI Summary
Agilent Technologies Inc. (A) CFO Bob McMahon to participate in fireside chat at the 44th Annual TD Cowen Health Care Conference. The event will take place in Boston, Massachusetts, on March 4, at 2:50 p.m. EST. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.26%
Tags
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has announced a partnership with Incyte to develop companion diagnostics (CDx) for Incyte’s hematology and oncology portfolio. The companion diagnostics market is expected to grow to nearly US $14B by 2030, driven by the increasing use of these tests to inform treatment decisions for a variety of cancers and chronic diseases. The collaboration will allow Agilent to expand its CDx portfolio with novel biomarkers, while leveraging Incyte’s expertise in IVD assay development and global regulatory approvals. The partnership aims to expedite the development of precision medicine products, potentially improving patient health outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) is set to release its financial results for the first quarter of fiscal year 2024, with the conference call scheduled to discuss the results. The call will be available for 90 days on the company's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.08%
Tags
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has announced the release of a new automated parallel capillary electrophoresis system for protein analysis, the Agilent ProteoAnalyzer system. The new platform simplifies and improves the efficiency of analyzing complex protein mixtures, benefiting diverse sectors from pharma to academia. The system brings added efficiency, versatility, and reliability, particularly in protein QC workflows. It can analyze different sizes and types of proteins in a single run and consistently deliver accurate results, reducing the need for time-consuming and costly reanalysis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.01%
Tags
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has been included in the Dow Jones Sustainability World Index and the North America Index for its strong environmental, social, and governance (ESG) performance. The company has been named in the Dow Jones Sustainability Indices for a ninth consecutive year, with only 3,500 of the largest companies globally eligible for inclusion. Agilent's sustainability performance was scored 'very high' on the S&P Global's annual Corporate Sustainability Assessment (CSA), far above the industry average in all three categories. The company is named in both the Dow Jones Sustainability World Index and the Dow Jones Sustainability North America Index, marking the ninth year of its inclusion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has moved its Cell Analysis Division into its Diagnostics and Genomics Group (DGG) to strengthen growth opportunities. This strategic move aims to align with customer needs and expand workflow coverage for accelerated growth. The company's cell analysis work, driven by acquisitions of BioTek Instruments, ACEA Biosciences, and Seahorse Bioscience, has been a significant growth driver. Agilent will report under the new structure starting from the first quarter fiscal 2024 results and will recast historical segment information accordingly.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.15%
Tags
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) CEO and CFO to present at 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has been recognized by the World Economic Forum as a Global Lighthouse for its manufacturing facility in Waldbronn, Germany. The facility is lauded for its innovative use of Fourth Industrial Revolution technologies, making it a model of smart manufacturing. Agilent is one of only 153 facilities worldwide to receive this distinction, and the only analytical and clinical laboratory technology company to be recognized.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.16%
Tags
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) announced that the Agilent Resolve Handheld Raman Spectrometer has been recognized for excellence as a tool for emergency responders by the UK’s National CBRN Centre and the US’ Department of Homeland Security.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) introduces water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader. These features enhance image quality for live-cell and 3D applications, reducing deleterious effects on live-cell samples and improving clarity for thicker samples such as tissues and 3-D spheroids.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
Agilent Technologies Inc
NYSE:A
A Stock Data
29.22B
284.18M
0.29%
91.65%
1.2%
Diagnostics & Research
Laboratory Analytical Instruments
United States
SANTA CLARA